NASDAQ:AVEO

AVEO Pharmaceuticals Earning Date

USA |NASDAQ |USD

AVEO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.36 $-0.40 $-0.33
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $13.80M $6.74M $3.60M

Aveo Pharmaceuticals's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

AVEO Earnings Date & History Chart

AVEO Earnings & Revenue Forecast

AVEO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.20 $-0.26 $-0.12
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-1.68 $-1.77 $-1.58
Dec 2022 4 $-0.17 $-0.68 $0.32

AVEO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.20 $-0.31 $-0.31
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.68 $-1.90 $-1.90
Dec 2022 0 / 0 $-0.17 $-0.16 $-0.16

AVEO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $22.40M $18.51M $27.15M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $45.66M $40.32M $54.98M
Dec 2022 4 $130.27M $93.78M $188.58M

AVEO Earnings Date & Revenue History

AVEO Earnings History

|
Show More
Show More

AVEO Revenue History

|
Show More
Show More

Aveo Pharmaceuticals Next Earnings Date & Report

AVEO Next Earnings Date & Report Preview: Sep 2021 (FQ)

AVEO's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Aveo Pharmaceuticals's next quarterly earnings is $-0.36, with a low EPS estimation of $-0.40, and a high estimation of $-0.29.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.36, the last 2 month trend is $-0.40, and the 3 month trend is $-0.40.

Based on 4 analysts, the average revenue estimation is $13.80M, with a low revenue estimation of $11.00M, and a high estimation of $18.36M.

Aveo Pharmaceuticals Previous Earnings Dates & Reports

AVEO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Aveo Pharmaceuticals's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

AVEO's earnings per share (EPS) was $-0.40, beating the consensus analysts forecast of $-0.50 by 19.60%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -50.62%, and higher than the same period a year before (Jun 2020) by -4.76%.

Revenues were $6.74M, worse than the forecast of $8.94M by -24.66%, up by 250.78% from the previous quarter , and up by 799.20% from the same period last year.

The company reported a net income of $-13.60M.

Free cash flow for the quarter was $-37.00M , compared to $-18.33M last quarter and $-7.53M a year before.

AVEO ended the quarter with $473.00K in total debt, a decrease of -98.57% compared to the previous quarter, and a decrease of -95.75% compared to the same quarter a year before.

AVEO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aveo Pharmaceuticals's previous annual earnings date was Mar 16, 2021 for its fiscal year ended Dec 31, 2020.

AVEO's earnings per share (EPS) was $-1.71, missing the consensus analysts forecast of $-1.60 by 6.87% , and lower than the previous year's EPS (Dec 2019) by -404.27%.

Revenues were $6.02M, worse than the forecast of $8.12M by -25.87%, and down by -79.10% from previous year's revenue.

The company reported a net income of $-35.58M.

Aveo Pharmaceuticals reported a free cash flow of $-38.35M for its fiscal year, compared to $-2.92M a year ago.

The company ended the fiscal year with $14.14M in total debt, a decrease of -10.31% compared to the previous year.